Profiling the nucleobase and structure selectivity of anticancer drugs and other DNA alkylating agents by RNA-Seq

May 10, 2018 Leave a comment 1,437 Views

Drugs that covalently modify DNA are components of most chemotherapy regimens, often serving as first-line treatments. Classically the chemical reactivity of DNA alkylators has been determined in vitro with...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: alkylating chemotherapeutics

Profiling the nucleobase and structure selectivity of anticancer drugs and other DNA alkylating agents by RNA-Seq

Transcriptomic entropy – a biologically relevant and interpretable metric for quantifying PSC-derived tissue maturation

Single-cell analysis of human skin identifies new cell type

NIH scientists build a cellular blueprint of multiple sclerosis lesions

RNA sequencing provides insights into the cellular and molecular changes in male infertility

The MAQC Society announces publication of a collection of next-gen sequencing best practice articles

New research provides useful genetic resource on farm-raised kuruma shrimp

Rutgers neurologist explores link between COVID and ‘Brain Fog,’ dementia with MRI and RNA sequencing